期刊文献+

抵克力得与川芎嗪联合治疗缺血性脑血管病的临床对比观察 被引量:4

Clinical comparison in treating ischemic cerebrovascular disesases with ticlopidine and Ligustrazine
暂未订购
导出
摘要 目的用中西医结合的方法观察抵克力得 (Ticlopidine)与川芎嗪联合治疗缺血性脑血管病的临床疗效。方法将 5 2例病人 ,男 2 8例 ,女 2 4例分为两组 ,治疗组 32例 ,对照组 2 0例 ,治疗组Ticlopidine 2 5 0mgqd ,川芎嗪 80~ 140mg divgttqd ,1个月为 1个疗程。对照组单用Ticlopidine 2 5 0mgqd。结果治疗组总有效率优于对照组 (P <0 0 5 ) ,1年后复发率治疗组 12 5 % ,对照组 30 % ,低于国内大宗病例与阿斯匹林的比较。结论中西医结合治疗缺血性脑血管病优于单用Ticolpidine的治疗 ,两者联合应用 ,既预防又治疗 ,两者兼顾。 Objective To observe the effect of Ticlopidine and Ligustrazine to treat Ischemic cerebrovascular diseases. Methods Fifty two patients of Ischemic cerebrovascular diseases that male 28,female 24 were divided in to two groups,with 32 patients in treated groups were given Ticlopidine 250mg qd and Ligustrazine 80~140mg ivgtt qd ,The coures of treatmant was one month, 20 patients as control group were given Ticlopidine 250mg qd only. Results The efficacy rate treated group was higher than that in control group ( P <0.05)and nervous function was improved markedly.The recurrence rate in treated group was 12.5%,in control group 30% after one year. The percentage was lower than that of most treated case with Aspirin. Conclusion Treating Ischemic cerebrovascular diseases with both tradtional Chinese medicine and western medicine was better than with Ticlopidine only and to patients may lead to preventative and curing effect.
出处 《贵州医药》 CAS 2000年第9期517-518,共2页 Guizhou Medical Journal
关键词 TICLOPIDINE 川芎嗪 缺血性脑血管病 Ticlopidine Ligustrazine Ischemic Cerebrovascular
  • 相关文献

参考文献2

共引文献9

同被引文献20

  • 1许国忠,许锦花,王俊科,滕宝润,盛卓人.川芎嗪对心肌保护的临床研究及电镜观察[J].中华麻醉学杂志,1994,14(6):445-447. 被引量:39
  • 2许国忠,孙宝春,王俊科,吕黄已,熊君宇,盛卓人.川芎嗪对血小板保护的研究[J].中华麻醉学杂志,1995,15(5):202-205. 被引量:29
  • 3黄枝优 黄枝宁 等.川芎嗪的药理及临床应用[J].中国医学文摘:内科学,1990,20(50):632-634.
  • 4Donna Mctavish Diana Fauldsand KarenL. Ticlopidine an updated review of its pharmacologogy and therapeutic use in plateletdependent disopders[J]. Drugs 1990,40(2): 238~259.
  • 5Hershey LA. Stroke prevention in Women:role of aspirin Versus Ticlopidine[J]. Am J Med, 1991,9 : 288.
  • 6Albers G. W. Role of Ticlopidine for prevention of stroke [J].stroke,1992,23(6): 912.
  • 7冯为民 方芳.川芎嗪治疗脑梗塞临床观察 [J].实用中西医结合杂志,1997,10(22):2206-2206.
  • 8Duncan PW,Jorgensen HS,Wade DT.Outcome measures in acute stroke trial:a systematic review and some recommendations to improve practice.Stroke 2000;31:1429-38
  • 9Schulz KF,Chalmers I,Hayes RJ.Empirical evidence of bias:dimensions of methodological quality associated with estimates of treatment effects in controlled trials.JAMA 1995;273:408-12
  • 10Jadad AR,Moore A,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:Is blinding necessary?Control Clin Trials 1996;17:1-12

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部